U.S., April 5 -- ClinicalTrials.gov registry received information related to the study (NCT06910384) titled 'A Study of STRO4 in Patients Amyotrophic Lateral Sclerosis (ALS)' on March 07.
Brief Summary: This study intends to evaluate the safety and efficacy of STR04 administered intravenously in participants with Amyotrophic Lateral Sclerosis.
Study Start Date: April 30
Study Type: INTERVENTIONAL
Condition:
Amyotrophic Lateral Sclerosis
Intervention:
BIOLOGICAL: STR04
autologous bone-marrow-derived mesenchymal stem cells
Recruitment Status: NOT_YET_RECRUITING
Sponsor: New England Cell Therapeutics, Inc.
Published by HT Digital Content Services with permission from Health Daily Digest....